Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
CHARBONE confirme la livraison de nouvelles commandes d'hydrogene UHP dans l'Etat de New York, un des principaux poles technologiques americains
CHARBONE Confirms the Delivery of New UHP Hydrogen Orders in New York State, One of the Main American Technology Hubs
